Intracellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
HQ location
New York City, United States
Website
Launch date
Employees
Market cap
$14.3b
Enterprise value
$13.3b
Share price
€122.00 23I.F
Authorizing premium user...